Financials data is unavailable for this security.
View more
Year on year Ekso Bionics Holdings Inc grew revenues 41.57% from 12.91m to 18.28m. Additionally the company has reduced the cost of goods sold, selling, general and administrative expenses and debt expenses (all as percentages of sales). These changes narrowed profitability losses from -15.08m to -15.20m.
Gross margin | 51.83% |
---|---|
Net profit margin | -68.41% |
Operating margin | -66.52% |
Return on assets | -40.75% |
---|---|
Return on equity | -83.20% |
Return on investment | -57.60% |
More ▼
Cash flow in USDView more
In 2023, cash reserves at Ekso Bionics Holdings Inc fell by 11.89m. Cash Flow from Financing totalled 348.00k or 1.90% of revenues. In addition the company used 12.05m for operations while cash used for investing totalled 157.00k.
Cash flow per share | -0.661 |
---|---|
Price/Cash flow per share | -- |
Book value per share | 0.6538 |
---|---|
Tangible book value per share | 0.3735 |
More ▼
Balance sheet in USDView more
Current ratio | 2.42 |
---|---|
Quick ratio | 1.77 |
Total debt/total equity | 0.4646 |
---|---|
Total debt/total capital | 0.3172 |
More ▼